Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
928.85
-7.50 (-0.80%)
< Home < Back

USFDA conducts inspection at Zydus Lifesciences’ Moraiya manufacturing facility in Ahmedabad

Date: 05-08-2022

The United States Food and Drug Administration (USFDA) has conducted an inspection of Zydus Lifesciences’ Moraiya manufacturing facility located at Ahmedabad from July 26, 2022 to August 5, 2022. The inspection concluded with four Form 483 observations. None of the observations were related to data integrity. The company will address the observations within the stipulated timeline.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.